QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
Public ClinicalTrials.gov record NCT02610296. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Study identification
- NCT ID
- NCT02610296
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Quark Pharmaceuticals
- Industry
- Enrollment
- 594 participants
Conditions and interventions
Conditions
Interventions
- QPI-1002 Drug
- Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 29, 2016
- Primary completion
- Jun 27, 2018
- Completion
- Jan 7, 2019
- Last update posted
- May 12, 2020
2016 – 2019
United States locations
- U.S. sites
- 36
- U.S. states
- 22
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35233 | — |
| Mayo Clinic Phoenix | Phoenix | Arizona | 85054 | — |
| University of California, Los Angeles | Los Angeles | California | 90024 | — |
| University of Southern California | Los Angeles | California | 90033 | — |
| University of California, Davis | Sacramento | California | 95817 | — |
| California Pacific Medical Center | San Francisco | California | 94115 | — |
| University of California, San Francisco | San Francisco | California | 94143 | — |
| Stanford University | Stanford | California | 94305 | — |
| University of Colorado, Denver | Aurora | Colorado | 80045 | — |
| Yale University | New Haven | Connecticut | 06519 | — |
| Georgetown Transplant Institute | Washington D.C. | District of Columbia | 20007 | — |
| University of Florida Health, Shands Hospital | Gainesville | Florida | 32608 | — |
| Tampa General Hospital | Tampa | Florida | 33606 | — |
| Emory University | Atlanta | Georgia | 30322 | — |
| University of Louisville | Louisville | Kentucky | 40202 | — |
| Ochsner Medical Center | New Orleans | Louisiana | 70121 | — |
| University of Maryland | Baltimore | Maryland | 21202 | — |
| University of Michigan | Ann Arbor | Michigan | 48109 | — |
| St. Barnabas Medical Center | Livingston | New Jersey | 07039 | — |
| Erie County Medical Center | Buffalo | New York | 14215 | — |
| Icahn School of Medicine at Mt. Sinai | New York | New York | 10029 | — |
| Columbia University | New York | New York | 10032 | — |
| New York - Presbyterian Hospital / Weill Cornell Medical Center | New York | New York | 10065 | — |
| SUNY Upstate NY University Hospital | Syracuse | New York | 13210 | — |
| Duke University | Durham | North Carolina | 27710 | — |
| Wake Forest University | Winston-Salem | North Carolina | 27103 | — |
| Ohio State University | Columbus | Ohio | 43210 | — |
| Integris Nazih Zuhdi Transplant Institute | Oklahoma City | Oklahoma | 73112 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| Baylor University Medical Center | Dallas | Texas | 75246 | — |
| Baylor All Saints | Fort Worth | Texas | 76104 | — |
| Houston Methodist Hospital | Houston | Texas | 77030 | — |
| University of Virginia | Charlottesville | Virginia | 22908 | — |
| Virginia Commonwealth University | Richmond | Virginia | 23298 | — |
| University of Washington | Seattle | Washington | 98195 | — |
| University of Wisconsin | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 48 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02610296, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 12, 2020 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02610296 live on ClinicalTrials.gov.